PellicarnosS.A.Active
Research and experimental development on biotechnology
KRS: 0001002168 NIP: 5252931775 REGON: 52365948700000
Overview
Registry date
2022-11-14
Share capital
$29,713.67
Activity description
Pellicarnos develops food for special medical purposes (FSMP) for patients who need metabolic support in clinical and home settings. The company offers Pellicar-F, a formula that supports healing of pressure sores and chronic wounds, and conducts research aimed at reducing the risk of pulmonary complications after surgery. Its products are developed with academic and clinical partners and are validated in laboratory and clinical testing.
Registered address
Ul. Zajęcza 15, 00-351 Warszawa, Poland
Website
pellicarnos.comWebsite inactive
Electronic delivery address
AE:PL-83187-60802-WBSHV-27
News
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| Pure BiologicsS.A. | $149,394.35 | purebiologics.com | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl/contact/wpdsa/ | |
| GenomtecS.A. | $73,665.75 | genomtec.com | |
| InventroS.A. | $12,176.61 | inventro.co | |
| ArthecS.A. | $10,911.16 | arthec.eu | |
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com |
FAQ
Last updated: 2026-07-16